Bacterial extracellular vesicles in the initiation, progression and treatment of atherosclerosis
Top Cited Papers
Open Access
- 22 January 2025
- journal article
- review article
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2452229
Abstract
Atherosclerosis is the primary cause of cardiovascular and cerebrovascular diseases. However, current anti-atherosclerosis drugs have shown conflicting therapeutic outcomes, thereby spurring the search for novel and effective treatments. Recent research indicates the crucial involvement of oral and gastrointestinal microbiota in atherosclerosis. While gut microbiota metabolites, such as choline derivatives, have been extensively studied and reviewed, emerging evidence suggests that bacterial extracellular vesicles (BEVs), which are membrane-derived lipid bilayers secreted by bacteria, also play a significant role in this process. However, the role of BEVs in host-microbiota interactions remains insufficiently explored. This review aims to elucidate the complex communication mediated by BEVs along the gut-heart axis. In this review, we summarize current knowledge on BEVs, with a specific focus on how pathogen-derived BEVs contribute to the promotion of atherosclerosis, as well as how BEVs from gut symbionts and probiotics may mitigate its progression. We also explore the potential and challenges associated with engineered BEVs in the prevention and treatment of atherosclerosis. Finally, we discuss the benefits and challenges of using BEVs in atherosclerosis diagnosis and treatment, and propose future research directions to address these issues.Keywords
This publication has 179 references indexed in Scilit:
- Bacteria‐Derived Outer‐Membrane Vesicles Hitchhike Neutrophils to Enhance Ischemic Stroke TherapyAdvanced Materials, 2023
- Bacterial extracellular vesicles: A position paper by the microbial vesicles task force of the Chinese society for extracellular vesiclesInterdisciplinary Medicine, 2023
- Aptamer‐based extracellular vesicle isolation, analysis and therapeuticsInterdisciplinary Medicine, 2023
- Extracellular vesicle‐based nucleic acid deliveryInterdisciplinary Medicine, 2023
- Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In VivoAdvanced Functional Materials, 2021
- Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United StatesJAMA Cardiology, 2020
- Outer membrane vesicles enhance tau phosphorylation and contribute to cognitive impairmentJournal of Cellular Physiology, 2019
- Extracellular Vesicle–Mimetic Ghost Nanovesicles for Delivering Anti‐Inflammatory Drugs to Mitigate Gram‐Negative Bacterial Outer Membrane Vesicle–Induced Systemic Inflammatory Response SyndromeAdvanced Healthcare Materials, 2018
- Porphyromonas gingivalis‐derived outer membrane vesicles promote calcification of vascular smooth muscle cells through ERK1/2‐RUNX2FEBS Open Bio, 2016
- Influenza vaccination to prevent myocardial infarction2004